The effect of Noshin Shahd herbal syrup on the glycemic index of patients with type 2 diabetes

Phase 2

Not yet recruiting

• Conditions: type 2 diabetes.; Type 2 diabetes mellitus with multiple complications; E11.7

• Registration Number: IRCT20221216056833N2
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Age between 20 and 65 years
Consistency of diet and exercise program
Body mass index less than 35
HbA1c more than 6.5
Not receiving insulin
The patient should take standard medicine except insulin

Exclusion Criteria

Performing CABG surgery, occurrence of ASC, heart and brain stroke, pulmonary embolism, deep vein thrombosis or TIA in the last 1 year
Taking anti-inflammatory drugs such as aspirin with an anti-inflammatory dose, antioxidant supplements, vitamins and omega-3 capsules (<1 g/day), and immunosuppressive drugs in the last three months
Presence of cancer, liver and thyroid diseases
pregnancy
Smoking and alcohol consumption

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HOMA-estimated insulin resistance. Timepoint: Before the intervention and 40 days after the intervention. Method of measurement: fasting insulin (mU/mL) × fasting glucose (mg/dL)/405.

Secondary Outcome Measures

Name	Time	Method
Oxidative stress factors. Timepoint: Before the intervention and 40 days after the intervention. Method of measurement: Spectrophotometry, Elisa kit.;Inflammatory biomarkers. Timepoint: Before the intervention and 40 days after the intervention. Method of measurement: Elisa kit, Turbidimetric assay.;Glycemic status. Timepoint: Before the intervention and 40 days after the intervention. Method of measurement: Biochemistry Autoanalyzer, Column chromatography, Elisa kit.;Hematopoietic status. Timepoint: Before the intervention and 40 days after the intervention. Method of measurement: CBC.;Biochemistry factors and lipid profile. Timepoint: Before the intervention and 40 days after the intervention. Method of measurement: Enzymatic assay.